Suppliers

Rosa & Co.

Rosa & Co. was established in 2002 and is known worldwide for the creation of PhysioPD™ Research Platforms and Rosa Market Modeling.

PhysioPD Research is a powerful component of modern drug development.  It is a proven quantitative systems pharmacology (QSP) approach that complements the expertise and experience of clinicians, guides more effective experimental and trial design, and enables deeper understanding of empirical data.  PhysioPD Research enables dramatically more effective learning about the connection of drug and disease mechanisms to relevant preclinical and clinical outcomes and supports more confident decisions at all stages in research and development.

The PhysioPD portfolio dovetails exquisitely with Rosa Market Modeling. Our key capability is to credibly identify what product attributes will drive physician demand and how a product’s potential range of performance on these attributes will compare to current and future competitive options.
Our clients use the results from Rosa Market Models for internal product planning discussions and for external communication with partners and investors to convey the commercial potential for their asset.

Learn more about our Mechanism to Market approach.

 

Rosa was founded in 2002 and remains an employee-owned, science-focused, and client-friendly firm. Today, Rosa is the worldwide commercial leader in PhysioPD-style Research, with comprehensive basic biology and therapeutic experience, industry-leading modeling expertise, and repeat research engagements with a majority of the Top 20 pharmaceutical companies.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings